Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(18%)
Results Posted
25%(2 trials)

Phase Distribution

Ph not_applicable
1
9%
Ph early_phase_1
1
9%
Ph phase_1
4
36%
Ph phase_2
1
9%
Ph phase_4
3
27%

Phase Distribution

5

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
4(40.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
3(30.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(8)

Detailed Status

Completed8
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 14 (40.0%)
Phase 21 (10.0%)
Phase 43 (30.0%)
N/A1 (10.0%)

Trials by Status

completed873%
recruiting218%
not_yet_recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11